Vaccines against pseudorabies virus (PrV)

Veterinary Microbiology

Volumn 206, Issue , 2017, Pages 3-9

  Freuling, C M ^a   Muller T F ^a   Mettenleiter, T C ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Aujeszky's disease virus; Marker vaccine; Pseudorabies virus; Recombinant vaccine; Suid herpesvirus 1

Indexed keywords

DNA VACCINE; LIVE VACCINE; MODIFIED LIVE PSEUDORABIES VACCINE; PSEUDORABIES VACCINE; PSEUDORABIES VIRUS ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS VECTOR;

ARTICLE; DNA IMMUNIZATION; NONHUMAN; PSEUDORABIES; PSEUDORABIES VIRUS; VACCINATION; ANIMAL; IMMUNOLOGY; PIG; SWINE DISEASE; VETERINARY; VIROLOGY;

ANIMALS; HERPESVIRUS 1, SUID; PSEUDORABIES; PSEUDORABIES VACCINES; SWINE; SWINE DISEASES; VACCINATION; VACCINES, ATTENUATED;

EID: 85007248654     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2016.11.019     Document Type: Article

References (101)

1. An, T.Q., Peng, J.M., Tian, Z.J., Zhao, H.Y., Li, N., Liu, Y.M., Chen, J.Z., Leng, C.L., Sun, Y., Chang, D., Tong, G.Z., Pseudorabies virus variant in bartha-K61-vaccinated pigs, China, 2012. Emerg. Infect. Dis. 19 (2013), 1749–1755.
2. Anonymous, 2010. “Strain lt-21/07” of aujeszky virus for manufacturing vaccines and diagnostic preparations, VGNKI, ed. (Russia).
3. Bartha, A., Experimental reduction of virulence of Aujeszky's disease virus (in Hungarian). Magy. Allatorv. Lapja 16 (1961), 42–45.
4. Brun, A., Albina, E., Barret, T., Chapman, D.A., Czub, M., Dixon, L.K., Keil, G.M., Klonjkowski, B., Le Potier, M.F., Libeau, G., Ortego, J., Richardson, J., Takamatsu, H.H., Antigen delivery systems for veterinary vaccine development: viral-vector based delivery systems. Vaccine 26 (2008), 6508–6528.
5. Canadian Food Insepction Agency 2012. http://www.inspection.gc.ca/animals/terrestrial-animals/diseases/reportable/pseudorabies/fact-sheet/eng/1329863644261/1329863975170 21.02.2012.
6. Cochran, M.D., 1995. Attenuated, genetically-engineered pseudorabies virus S-PRV-155 and uses thereof (Google Patents).
7. Cong, X., Lei, J.-L., Xia, S.-L., Wang, Y.-M., Li, Y., Li, S., Luo, Y., Sun, Y., Qiu, H.-J., Pathogenicity and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant in susceptible animals. Vet. Microbiol. 182 (2016), 170–177.
8. Dong, B., Zarlenga, D.S., Ren, X., An overview of live attenuated recombinant pseudorabies viruses for use as novel vaccines. J. Immunol. Res., 2014, 2014, 824630.
9. Dory, D., Torche, A.M., Beven, V., Blanchard, P., Loizel, C., Cariolet, R., Jestin, A., Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins. Vaccine 23 (2005), 3483–3491.
10. Doudna, J.A., Charpentier, E., The new frontier of genome engineering with CRISPR-Cas9. Science, 346, 2014, 1258096.
11. Dufour, V., Chevallier, S., Cariolet, R., Somasundaram, S., Lefevre, F., Jestin, A., Albina, E., Induction of porcine cytokine mRNA expression after DNA immunization and pseudorabies virus infection. J. Interferon Cytokine Res. 20 (2000), 889–895.
12. European Commission, Bovine and Swine Diseases: 2014 Annual Report., 2014, European Commission.
13. European Commission, COMMISSION IMPLEMENTING DECISION (EU) 2015/398 of 13 February 2015 amending Decision 2008/185/EC as regards the inclusion of Hungary in the list of Member States or regions thereof free of Aujeszky's diseasee. Off. J. Eur. Union L 66 (2015), 16–19.
14. Fenner, F., Bachman, P.A., Gibbs, E.J.P., Herpesviridae. Fenner, F., Bachmann, P.A., Gibbs, E.J.P., (eds.) Eterinary Virology, 1987, Academic Press Inc, San Diego, 353–356.
15. Ferrari, M., Brack, A., Romanelli, M.G., Mettenleiter, T.C., Corradi, A., Dal Mas, N., Losio, M.N., Silini, R., Pinoni, C., Pratelli, A., A study of the ability of a TK-negative and gI/gE-negative pseudorabies virus (PRV) mutant inoculated by different routes to protect pigs against PRV infection. J. Vet. Med. B Infect. Dis. Vet. Public Health 47 (2000), 753–762.
16. Fischer, T., Planz, O., Stitz, L., Rziha, H.J., Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice. J. Virol. 77 (2003), 9312–9323.
17. Gerdts, V., Jons, A., Makoschey, B., Visser, N., Mettenleiter, T.C., Protection of pigs against Aujeszky's disease by DNA vaccination. J. Gen. Virol. 78 (1997), 2139–2146.
18. Gielkens, A.L., van Oirschot, J.T., Berns, A.J., Genome differences among field isolates and vaccine strains of pseudorabies virus. J. Gen. Virol. 66 (1985), 69–82.
19. Grabowska, A.K., Lipinska, A.D., Rohde, J., Szewczyk, B., Bienkowska-Szewczyk, K., Rziha, H.J., New baculovirus recombinants expressing Pseudorabies virus (PRV) glycoproteins protect mice against lethal challenge infection. Vaccine 27 (2009), 3584–3591.
20. Gut, M., Jacobs, L., Tyborowska, J., Szewczyk, B., Bienkowska-Szewczyk, K., A highly specific and sensitive competitive enzyme-linked immunosorbent assay (ELISA) based on baculovirus expressed pseudorabies virus glycoprotein gE and gI complex. Vet. Microbiol. 69 (1999), 239–249.
21. Hahn, E.C., Fadl-Alla, B., Lichtensteiger, C.A., Variation of Aujeszky's disease viruses in wild swine in USA. Vet. Microbiol. 143 (2010), 45–51.
22. Han, Y.W., Aleyas, A.G., George, J.A., Kim, S.J., Kim, H.K., Yoon, H.A., Yoo, D.J., Kang, S.H., Kim, K., Eo, S.K., Polarization of protective immunity induced by replication-incompetent adenovirus expressing glycoproteins of pseudorabies virus. Exp. Mol. Med. 40 (2008), 583–595.
23. Hirschberg, H.J., van Riet, E., Oosterhoff, D., Bouwstra, J.A., Kersten, G.F., Animal models for cutaneous vaccine delivery. Eur. J. Pharm. Sci. 71 (2015), 112–122.
24. Hong, Q., Qian, P., Li, X.M., Yu, X.L., Chen, H.C., A recombinant pseudorabies virus co-expressing capsid proteins precursor P1-2A of FMDV and VP2 protein of porcine parvovirus: a trivalent vaccine candidate. Biotechnol. Lett. 29 (2007), 1677–1683.
25. Hu, R.M., Zhou, Q., Song, W.B., Sun, E.C., Zhang, M.M., He, Q.G., Chen, H.C., Wu, B., Liu, Z.F., Novel pseudorabies virus variant with defects in TK, gE and gI protects growing pigs against lethal challenge. Vaccine 33 (2015), 5733–5740.
26. Ishikawa, K., Jin-yama, M., Saitoh, A., Takagi, M., Muramatsu, M., Itoh, O., Differentiation between glycoprotein III gene-deleted vaccine and wild- type strains of pseudorabies virus by polymerase chain reaction (PCR). J. Virol. Methods 51 (1995), 267–276.
27. Katz, J.B., Pedersen, J.C., Molecular analysis of pseudorabies viral vaccines and their rapid differentiation from wild-type isolates using DNA-amplified glycoprotein I and thymidine kinase gene segment polymorphisms. Biologicals 20 (1992), 187–195.
28. Kimman, T.G., de Leeuw, O., Kochan, G., Szewczyk, B., van Rooij, E., Jacobs, L., Kramps, J.A., Peeters, B., An indirect double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) using baculovirus-expressed antigen for the detection of antibodies to glycoprotein E of pseudorabies virus and comparison of the method with blocking ELISAs. Clin. Diagn. Lab. Immunol. 3 (1996), 167–174.
29. Kinker, D.R., Swenson, S.L., Wu, L.L., Zimmerman, J.J., Evaluation of serological tests for the detection of pseudorabies gE antibodies during early infection. Vet. Microbiol. 55 (1997), 99–106.
30. Kit, S., Kit, M., Pirtle, E.C., Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus. Am. J. Vet. Res. 46 (1985), 1359–1367.
31. Kit, S., Sheppard, M., Ichimura, H., Kit, M., Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes. Am. J. Vet. Res. 48 (1987), 780–793.
32. Klingbeil, K., Lange, E., Teifke, J.P., Mettenleiter, T.C., Fuchs, W., Immunization of pigs with an attenuated pseudorabies virus recombinant expressing the haemagglutinin of pandemic swine origin H1N1 influenza A virus. J. Gen. Virol. 95 (2014), 948–959.
33. Kluge, J.P., Beran, G.W., Hill, H.T., Platt, K.B., Pseudorabies (Aujeszky's disease). Straw, B.E., D'Allaire, S., Mengeling, W.L., Taylor, D.J., (eds.) Diseases of Swine, 1999, Iowa State University Press, Ames, Iowa, 233–246.
34. Klupp, B.G., Kern, H., Mettenleiter, T.C., The virulence-determining genomic BamHI fragment 4 of pseudorabies virus contains genes corresponding to the UL15 (partial), UL18, UL19, UL20, and UL21 genes of herpes simplex virus and a putative origin of replication. Virology 191 (1992), 900–908.
35. Klupp, B.G., Hengartner, C.J., Mettenleiter, T.C., Enquist, L.W., Complete, annotated sequence of the pseudorabies virus genome. J. Virol. 78 (2004), 424–440.
36. Kretzschmar, C., Eradication and control of aujeszky‘s disease in the german democratic republic. van Oirschot, J.T., (eds.) Seminar in the Community Programme for the Coordination of Agricultural Research, 1989, Kluwer Academic Brussels, Belgium 5–6 July.
37. Le Luduec, J.B., Debeer, S., Piras, F., Andreoni, C., Boudet, F., Laurent, P., Kaiserlian, D., Dubois, B., Intradermal vaccination with un-adjuvanted sub-unit vaccines triggers skin innate immunity and confers protective respiratory immunity in domestic swine. Vaccine 34 (2016), 914–922.
38. Lei, J.L., Xia, S.L., Wang, Y., Du, M., Xiang, G.T., Cong, X., Luo, Y., Li, L.F., Zhang, L., Yu, J., Hu, Y., Qiu, H.J., Sun, Y., Safety and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant expressing the E2 protein of classical swine fever virus in pigs. Immunol. Lett. 174 (2016), 63–71.
39. Liang, X., Sun, L., Yu, T., Pan, Y., Wang, D., Hu, X., Fu, Z., He, Q., Cao, G., A CRISPR/Cas9 and Cre/Lox system-based express vaccine development strategy against re-emerging Pseudorabies virus. Sci. Rep., 6, 2016, 19176.
40. Lomniczi, B., Blankenship, M.L., Ben-Porat, T., Deletions in the genomes of pseudorabies virus vaccine strains and existence of four isomers of the genomes. J. Virol. 49 (1984), 970–979.
41. Lomniczi, B., Watanabe, S., Ben-Porat, T., Kaplan, A.S., Genetic basis of the neurovirulence of pseudorabies virus. J. Virol. 52 (1984), 198–205.
42. Lomniczi, B., Kaplan, A.S., Ben-Porat, T., Multiple defects in the genome of pseudorabies virus can affect virulence without detectably affecting replication in cell culture. Virology 161 (1987), 181–189.
43. Müller, T., Bätza, H.J., Schlüter, H., Conraths, F.J., Mettenleiter, T.C., Eradication of aujeszky's disease in Germany. J. Vet. Med. B Infect. Dis. Vet. Public Health 50 (2003), 207–213.
44. Müller, T., Hahn, E.C., Tottewitz, F., Kramer, M., Klupp, B.G., Mettenleiter, T.C., Freuling, C., Pseudorabies virus in wild swine: a global perspective. Arch. Virol. 156 (2011), 1691–1705.
45. Ma, X.J., Cui, Y.C., Qiu, Z., Zhang, B.K., Cui, S.J., A nanoparticle-assisted PCR assay to improve the sensitivity for rapid detection and differentiation of wild-type pseudorabies virus and gene-deleted vaccine strains. J. Virol. Methods 193 (2013), 374–378.
46. MacDiarmid, S.C., Aujeszky's disease eradication in New Zealand. Aust. Vet. J. 78 (2000), 470–471.
47. Maresch, C., Lange, E., Teifke, J.P., Fuchs, W., Klupp, B., Muller, T., Mettenleiter, T.C., Vahlenkamp, T.W., Oral immunization of wild boar and domestic pigs with attenuated live vaccine protects against Pseudorabies virus infection. Vet. Microbiol. 161 (2012), 20–25.
48. Meeusen, E.N., Walker, J., Peters, A., Pastoret, P.P., Jungersen, G., Current status of veterinary vaccines. Clin. Microbiol. Rev. 20 (2007), 489–510.
49. Meliota, F., Lomniczi, B., Immunogenicity of live aujeszky-vaccine strain lombart in fattening pigs. 14th International Pig Veterinary Society Congress, Bologna, Italy, 7–10 July, 1996 (161-161).
50. Mengeling, W.L., Lager, K.M., Volz, D.M., Brockmeier, S.L., Effect of various vaccination procedures on shedding, latency, and reactivation of attenuated and virulent pseudorabies virus in swine. Am. J. Vet. Res. 53 (1992), 2164–2173.
51. Mengeling, W.L., Brockmeier, S.L., Lager, K.M., Vorwald, A.C., The role of biotechnologically engineered vaccines and diagnostics in pseudorabies (Aujeszky's disease) eradication strategies. Vet. Microbiol. 55 (1997), 49–60.
52. Mettenleiter, T.C., Lukacs, N., Rziha, H.J., Mapping of the structural gene of pseudorabies virus glycoprotein A and identification of two non-glycosylated precursor polypeptides. J. Virol. 53 (1985), 52–57.
53. Mettenleiter, T.C., Lukacs, N., Rziha, H.J., Pseudorabies virus avirulent strains fail to express a major glycoprotein. J. Virol. 56 (1985), 307–311.
54. Mettenleiter, T.C., Klupp, B.G., Weiland, F., Visser, N., Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine. J. Gen. Virol. 75 (1994), 1723–1733.
55. Mettenleiter, T.C., Ehlers, B., Müller, T., Yoon, K., Teifke, J.P., Herpesviruses. Zimmerman, J., Karriker, L.A., Ramirez, A., Schwartz, K.J., Stevenson, G.W., (eds.) Diseases of Swine, 2012, John Wiley & Sons, Inc. Published 2012 by John Wiley & Sons, Inc., 421–446.
56. Mettenleiter, T.C., Aujeszky's disease (pseudorabies) virus: the virus and molecular pathogenesis − State of the art June 1999. Vet. Res. 31 (2000), 99–115.
57. Moormann, R.J., de Rover, T., Briaire, J., Peeters, B.P., Gielkens, A.L., van Oirschot, J.T., Inactivation of the thymidine kinase gene of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain. J. Gen. Virol. 71 (1990), 1591–1595.
58. Nara, P.L., Nara, D., Chaudhuri, R., Lin, G., Tobin, G., Perspectives on advancing preventative medicine through vaccinology at the comparative veterinary, human and conservation medicine interface: not missing the opportunities. Vaccine 26 (2008), 6200–6211.
59. Nauwynck, H., Labarque, G.G., Pensaert, M., Efficacy of an intranasal immunization with gEgC andgEgI double-deletion mutants of Aujeszky's disease virus in maternally immune pigs and the effects of a successive intramuscular booster with commercial vaccines. J. Vet. Med. Ser. B 46 (1999), 713–722.
60. Nauwynck, H., Glorieux, S., Favoreel, H., Pensaert, M., Cell biological and molecular characteristics of pseudorabies virus infections in cell cultures and in pigs with emphasis on the respiratory tract. Vet. Res. 38 (2007), 229–241.
61. Pasik, J., Application of DIVA vaccines and their companion diagnostic tests to foreign animal disease eradication. Anim. Health Res. Rev. 5 (2004), 257–262.
62. Peeters, B., Bouma, A., de Bruin, T., Moormann, R., Gielkens, A., Kimman, T., Non-transmissible pseudorabies virus gp50 mutants: a new generation of safe live vaccines. Vaccine 12 (1994), 375–380.
63. Peeters, B., Bienkowska-Szewczyk, K., Hulst, M., Gielkens, A., Kimman, T., Biologically safe, non-transmissible pseudorabies virus vector vaccine protects pigs against both Aujeszky's disease and classical swine fever. J. Gen. Virol. 78 (1997), 3311–3315.
64. Pensaert, M.B., Kluge, P., Pseudorabies virus (Aujeszky's disease). Pensaert, M., (eds.) Virus Infections of Porcines, 1989, Elsevier Science Publishers, New York, 39–64.
65. Petrovskis, E.A., Timmins, J.G., Gierman, T.M., Post, L.E., Deletions in vaccine strains of pseudorabies virus and their effect on synthesis of glycoprotein gp63. J. Virol. 60 (1986), 1166–1169.
66. Quint, W., Gielkens, A., Vanoirschot, J., Berns, A., Cuypers, H.T., Construction and characterization of deletion mutants of pseudorabies virus − a new generation of live vaccines. J. Gen. Virol. 68 (1987), 523–534.
67. Rios, A.C., Moutinho, C.G., Pinto, F.C., Del Fiol, F.S., Jozala, A., Chaud, M.V., Vila, M.M.D.C., Teixeira, J.A., Balcão, V.M., Alternatives to overcoming bacterial resistances State-of-the-art. Microbiol. Res. 191 (2016), 51–80.
68. Robbins, A.K., Ryan, J.P., Whealy, M.E., Enquist, L.W., The gene encoding the gIII envelope protein of pseudorabies virus vaccine strain Bartha contains a mutation affecting protein localization. J. Virol. 63 (1989), 250–258.
69. Rossi, S., Staubach, C., Blome, S., Guberti, V., Thulke, H.H., Vos, A., Koenen, F., Le Potier, M.F., Controlling of CSFV in European wild boar using oral vaccination: a review. Front. Microbiol., 6, 2015, 1141.
70. Russell, W.C., Update on adenovirus and its vectors. J. Gen. Virol. 81 (2000), 2573–2604.
71. Secretaría de Agricultura, Ganadería Desarrollo Rural Pesca y Alimentación 2015. http://www.gob.mx/sagarpa/prensa/sagarpa-declara-a-mexico-como-pais-libre-de-la-enfermedad-aujeszky-en-la-porcicultura-nacional. 24 de junio de 2015.
72. Skoda, R., Brauner, I., S'Adecky, E., Somogyiova, J., mmunization against aujeszky's disease with live vaccine. Ii. Immunization of pigs under laboratory conditions. Acta Virol. 8 (1964), 123–134.
73. Skoda, R., Brauner, I., Sadecky, E., Mayer, V., Immunization against aujeszky's disease with live vaccine: i. Attenuation of virus and some properties of attenuated strains. Acta Virol. 8 (1964), 1–9.
74. Stegeman, A., Pseudorabies virus eradication by area-wide vaccination is feasible. Vet. Q. 17 (1995), 150–156.
75. Swenson, S.L., McMillen, J., Hill, H.T., Evaluation of the safety and efficacy of a thymidine kinase, inverted repeat, gI, and gpX gene-deleted pseudorabies vaccine. J. Vet. Diagn. Invest. 5 (1993), 341–346.
76. Tatarov, G., An apathogenic mutant of the Aujeszky virus induced by 5-iodo-2-deoxyuridine (IDU). Zentralbl Veterinarmed [B] 15 (1968), 847–853.
77. Todd, D., McFerran, J.B., Restriction endonuclease analysis of Aujeszky's disease (pseudorabies) virus DNA: comparison of Northern Ireland isolates and isolates from other countries. Arch. Virol. 86 (1985), 167–176.
78. Toma, B., Brun, A., Vannier, P., Chappuis, G., Modification of a strain of Aujeszky's disease virus in cell culture. Ann. Zootech., 26, 1977 453–453.
79. Tong, W., Li, G., Liang, C., Liu, F., Tian, Q., Cao, Y., Li, L., Zheng, X., Zheng, H., Tong, G., A live, attenuated pseudorabies virus strain JS-2012 deleted for gE/gI protects against both classical and emerging strains. Antiviral Res. 130 (2016), 110–117.
80. United States Department of Agriculture Animal and Plant Health Inspection Service, 2008. Pseudorabies (Aujeszky's Disease) and Its Eradication. A Review of the U.S. Experience. Technical Bulletin No. 1923.
81. Van Oirschot, J.T., Intranasal vaccination of pigs against Aujeszky's disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres. Res. Vet. Sci. 42 (1987), 12–16.
82. Vannier, P., Vaccination against Aujeszky's disease by different routes using live attenuated and inactivated virus vaccines in pigs with or without passive immunity. Zentralbl Veterinarmed [B] 33 (1986), 704–712.
83. Visser, N., Lütticken, D., Experiences with a gl-/tk modified live pseudorabies virus vaccine: strain Begonia. Van Oirschot, J.T., (eds.) Proceedings of the CEC Seminar on Vaccination and Control of Aujeszky's Disease, 1989, Kluwer Academic, 37–44.
84. Wang, C.H., Yuan, J., Qin, H.Y., Luo, Y., Cong, X., Li, Y., Chen, J., Li, S., Sun, Y., Qiu, H.J., A novel gE-deleted pseudorabies virus (PRV) provides rapid and complete protection from lethal challenge with the PRV variant emerging in Bartha-K61-vaccinated swine population in China. Vaccine 32 (2014), 3379–3385.
85. Wardley, R.C., Post, L.E., The use of the gX deleted vaccine PRV (−)TK(−)gX-1 in the control of Aujeszky's Disease. Van Oirschot, J.T., (eds.) Proceedings of the CEC Seminar on Vaccination and Control of Aujeszky's Disease, 1989, Kluwer Academic, 13–25.
86. Wernike, K., Beer, M., Freuling, C.M., Klupp, B., Mettenleiter, T.C., Muller, T., Hoffmann, B., Molecular double-check strategy for the identification and characterization of Suid herpesvirus 1. J. Virol. Methods 209 (2014), 110–115.
87. World Organisation for Animal Health (OIE), Aujeszky's disease – chapter 2.1.2. Terrestrial Animal Health Code, 2012, OIE, Paris.
88. Wu, R., Bai, C., Sun, J., Chang, S., Zhang, X., Emergence of virulent pseudorabies virus infection in northern China. J. Vet. Sci. 14 (2013), 363–365.
89. Wu, C.-Y., Liao, C.-M., Chi, J.-N., Chien, M.-S., Huang, C., Growth properties and vaccine efficacy of recombinant pseudorabies virus defective in glycoprotein E and thymidine kinase genes. J. Biotechnol. 229 (2016), 58–64.
90. Yang, D.-K., Kim, H.-H., Choi, S.-S., Hyun, B.-H., Song, J.-Y., An oral Aujeszky's disease vaccine (YS-400) induces neutralizing antibody in pigs. Clin. Exp. Vaccine Res. 5 (2016), 132–137.
91. Zhang, C., Guo, L., Jia, X., Wang, T., Wang, J., Sun, Z., Wang, L., Li, X., Tan, F., Tian, K., Construction of a triple gene-deleted Chinese Pseudorabies virus variant and its efficacy study as a vaccine candidate on suckling piglets. Vaccine 33 (2015), 2432–2437.
92. Zhu, L., Yi, Y., Xu, Z., Cheng, L., Tang, S., Guo, W., Growth, physicochemical properties, and morphogenesis of Chinese wild-type PRV Fa and its gene-deleted mutant strain PRV SA215. Virol. J., 8, 2011 272–272.
93. van Oirschot, J.T., Gielkens, A.L., Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus. Am. J. Vet. Res. 45 (1984), 2099–2103.
94. van Oirschot, J.T., Rziha, H.J., Moonen, P.J., Pol, J.M., van Zaane, D., Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay. J. Gen. Virol. 67 (1986), 1179–1182.
95. van Oirschot, J.T., Gielkens, A.L., Moormann, R.J., Berns, A.J., Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's disease. Vet. Microbiol. 23 (1990), 85–101.
96. van Oirschot, J.T., Kaashoek, M.J., Rijsewijk, F.A., Stegeman, J.A., The use of marker vaccines in eradication of herpesviruses. J. Biotechnol. 44 (1996), 75–81.
97. van Oirschot, J.T., Diva vaccines that reduce virus transmission. J. Biotechnol. 73 (1999), 195–205.
98. van Rooij, E.M.A., de Bruin, M.G.M., de Visser, Y.E., Boersma, W., Bianchi, A.T.J., Analysis of protective immunity against PRV infection in pigs using attenuated and inactivated PRV vaccines. Vet. Res., 31, 2000, 135.
99. van Rooij, E.M., Rijsewijk, F.A., Moonen-Leusen, H.W., Bianchi, A.T., Rziha, H.J., Comparison of different prime-boost regimes with DNA and recombinant Orf virus based vaccines expressing glycoprotein D of pseudorabies virus in pigs. Vaccine 28 (2010), 1808–1813.
100. van Zijl, M., Wensvoort, G., de Kluyver, E., Hulst, M., van der Gulden, H., Gielkens, A., Berns, A., Moormann, R., Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J. Virol. 65 (1991), 2761–2765.
101. van der Leek, M.L., Feller, J.A., Sorensen, G., Isaacson, W., Adams, C.L., Borde, D.J., Pfeiffer, N., Tran, T., Moyer, R.W., Gibbs, E.P., Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63. Vet. Rec. 134 (1994), 13–18.